Dömling A - Search Results

1

Robust NMR screening for lead compounds using tryptophan-containing proteins.

Bista M, Kowalska K, Janczyk W, Dömling A, Holak TA. Bista M, et al. Among authors: domling a. J Am Chem Soc. 2009 Jun 10;131(22):7500-1. doi: 10.1021/ja901863h. J Am Chem Soc. 2009. PMID: 19422216

2

Rapid and efficient hydrophilicity tuning of p53/mdm2 antagonists.

Srivastava S, Beck B, Wang W, Czarna A, Holak TA, Dömling A. Srivastava S, et al. Among authors: domling a. J Comb Chem. 2009 Jul-Aug;11(4):631-9. doi: 10.1021/cc9000218. J Comb Chem. 2009. PMID: 19548636 Free PMC article.

3

Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery.

Popowicz GM, Czarna A, Wolf S, Wang K, Wang W, Dömling A, Holak TA. Popowicz GM, et al. Among authors: domling a. Cell Cycle. 2010 Mar 15;9(6):1104-11. doi: 10.4161/cc.9.6.10956. Epub 2010 Mar 15. Cell Cycle. 2010. PMID: 20237429

4

1,4-Thienodiazepine-2,5-diones via MCR (I): synthesis, virtual space and p53-Mdm2 activity.

Huang Y, Wolf S, Bista M, Meireles L, Camacho C, Holak TA, Dömling A. Huang Y, et al. Among authors: domling a. Chem Biol Drug Des. 2010 Aug;76(2):116-29. doi: 10.1111/j.1747-0285.2010.00989.x. Epub 2010 May 18. Chem Biol Drug Des. 2010. PMID: 20492448 Free PMC article.

5

Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists.

Czarna A, Beck B, Srivastava S, Popowicz GM, Wolf S, Huang Y, Bista M, Holak TA, Dömling A. Czarna A, et al. Among authors: domling a. Angew Chem Int Ed Engl. 2010 Jul 19;49(31):5352-6. doi: 10.1002/anie.201001343. Angew Chem Int Ed Engl. 2010. PMID: 20575124 Free PMC article. No abstract available.

6

The structure-based design of Mdm2/Mdmx-p53 inhibitors gets serious.

Popowicz GM, Dömling A, Holak TA. Popowicz GM, et al. Among authors: domling a. Angew Chem Int Ed Engl. 2011 Mar 14;50(12):2680-8. doi: 10.1002/anie.201003863. Epub 2011 Feb 21. Angew Chem Int Ed Engl. 2011. PMID: 21341346 Free PMC article. Review.

7

Exhaustive fluorine scanning toward potent p53-Mdm2 antagonists.

Huang Y, Wolf S, Koes D, Popowicz GM, Camacho CJ, Holak TA, Dömling A. Huang Y, et al. Among authors: domling a. ChemMedChem. 2012 Jan 2;7(1):49-52. doi: 10.1002/cmdc.201100428. Epub 2011 Sep 27. ChemMedChem. 2012. PMID: 21954050 Free PMC article. No abstract available.

8

Enabling large-scale design, synthesis and validation of small molecule protein-protein antagonists.

Koes D, Khoury K, Huang Y, Wang W, Bista M, Popowicz GM, Wolf S, Holak TA, Dömling A, Camacho CJ. Koes D, et al. Among authors: domling a. PLoS One. 2012;7(3):e32839. doi: 10.1371/journal.pone.0032839. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427896 Free PMC article.

9

Benzimidazole-2-one: a novel anchoring principle for antagonizing p53-Mdm2.

Wang W, Cao H, Wolf S, Camacho-Horvitz MS, Holak TA, Dömling A. Wang W, et al. Among authors: domling a. Bioorg Med Chem. 2013 Jul 15;21(14):3982-95. doi: 10.1016/j.bmc.2012.06.020. Epub 2012 Jun 20. Bioorg Med Chem. 2013. PMID: 22789708 Free PMC article.

10

Mdm2 and MdmX inhibitors for the treatment of cancer: a patent review (2011-present).

Zak K, Pecak A, Rys B, Wladyka B, Dömling A, Weber L, Holak TA, Dubin G. Zak K, et al. Among authors: domling a. Expert Opin Ther Pat. 2013 Apr;23(4):425-48. doi: 10.1517/13543776.2013.765405. Epub 2013 Feb 4. Expert Opin Ther Pat. 2013. PMID: 23374098 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters